Press-release for stocks for SNY

symbols : SNY crawled time : 16:00

save search

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 2.43% | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M

Health Technology

| -0.65% | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.64 -1.73% -3.9% 8.2K

Health Technology

| -1.72% | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
RLYB | News | $1.58 -9.2% -9.43% 250K

| -10.23% | O: 1.14% H: 3.37% C: -0.56%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| 0.16% | O: 0.29% H: 0.0% C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M

Health Technology

| -6.58% | O: 2.63% H: 2.56% C: -2.56%
TXMD | News | $1.92 2.13% -0.27% 15K

Health Technology

| 3.23% | O: 0.54% H: 3.21% C: 0.53%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 3.4% | O: 0.85% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K

Health Technology

| -0.43% | O: 0.08% H: 4.54% C: 2.49%
NKTR | News | $1.38 -2.82% -2.16% 960K

Health Technology

| 11.29% | O: 5.65% H: 7.63% C: 3.82%
MOR | News | $18.05 0.06% 0.17% 130K

Health Technology

| 0.39% | O: -0.06% H: 0.0% C: 0.0%
GLPG | News | $28.77 -2.31% -2.33% 130K

Health Technology

| -1.07% | O: -0.41% H: 1.52% C: 0.38%
AMRN | News | $0.8786 -0.53% 0.12% 640K

Health Technology

| -0.03% | O: -2.31% H: 2.33% C: 1.16%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M

Technology Services

| 3.27% | O: 0.14% H: 2.16% C: 1.28%
GOOG | News 4 | $161.1 0.74% 0.7% 16M

Technology Services

| 3.45% | O: 0.19% H: 2.04% C: 1.24%
OCX | News | $2.46 0.2% -6.74% 40K

Health Technology

| -1.6% | O: 0.8% H: 1.59% C: -0.4%
biopharma

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-19 (Crawled : 16:00) - biospace.com/
RLYB | News | $1.58 -9.2% -9.43% 250K

| -7.6% | O: -3.51% H: 10.3% C: 6.67%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| 2.2% | O: 0.83% H: 1.35% C: 1.2%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M

Health Technology

| -18.39% | O: -5.75% H: 4.88% C: -7.32%
TXMD | News | $1.92 2.13% -0.27% 15K

Health Technology

| 1.59% | O: -0.53% H: 5.32% C: -1.06%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 4.25% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K

Health Technology

| 0.2% | O: -4.57% H: 6.41% C: 5.46%
NKTR | News | $1.38 -2.82% -2.16% 960K

Health Technology

| 2.22% | O: -1.48% H: 0.0% C: -6.77%
MOR | News | $18.05 0.06% 0.17% 130K

Health Technology

| 0.0% | O: -0.17% H: 0.11% C: -0.22%
GLPG | News | $28.77 -2.31% -2.33% 130K

Health Technology

| -1.54% | O: -1.23% H: 0.94% C: 0.76%
AMRN | News | $0.8786 -0.53% 0.12% 640K

Health Technology

| -5.27% | O: -5.24% H: 0.0% C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M

Technology Services

| 2.46% | O: 0.57% H: 0.1% C: -1.35%
GOOG | News 4 | $161.1 0.74% 0.7% 16M

Technology Services

| 2.67% | O: 0.54% H: 0.15% C: -1.29%
OCX | News | $2.46 0.2% -6.74% 40K

Health Technology

| -5.02% | O: -1.93% H: 0.39% C: -1.57%
biopharma

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -0.53% | O: 0.69% H: 0.0% C: 0.0%
health als granted canada

Biopharma Layoff Tracker 2024: Xilio, Bayer, BMS and More Cut Staff
Published: 2024-03-28 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -5.72% | O: -1.17% H: 0.0% C: -0.89%
RLYB | News | $1.58 -9.2% -9.43% 250K

| -0.63% | O: 0.63% H: 16.25% C: 15.63%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -5.1% | O: 1.32% H: 0.0% C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M

Health Technology

| -44.96% | O: 3.1% H: 6.02% C: -2.26%
TXMD | News | $1.92 2.13% -0.27% 15K

Health Technology

| -15.79% | O: -0.88% H: 2.21% C: 1.33%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -4.58% | O: -0.96% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K

Health Technology

| -14.37% | O: 0.14% H: 1.19% C: -1.32%
NKTR | News | $1.38 -2.82% -2.16% 960K

Health Technology

| 55.91% | O: -0.58% H: 6.82% C: 6.16%
MOR | News | $18.05 0.06% 0.17% 130K

Health Technology

| -0.5% | O: 0.06% H: 0.06% C: -0.06%
GLPG | News | $28.77 -2.31% -2.33% 130K

Health Technology

| -12.69% | O: -2.34% H: 0.09% C: 0.06%
AMRN | News | $0.8786 -0.53% 0.12% 640K

Health Technology

| -1.03% | O: -1.03% H: 3.41% C: 1.23%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M

Technology Services

| 5.47% | O: -0.01% H: 0.38% C: 0.05%
GOOG | News 4 | $161.1 0.74% 0.7% 16M

Technology Services

| 6.03% | O: 0.04% H: 0.44% C: 0.17%
OCX | News | $2.46 0.2% -6.74% 40K

Health Technology

| -16.33% | O: 0.0% H: 2.44% C: -0.34%
biopharma

FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
Published: 2024-03-25 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| 0.3% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -1.3% | O: 0.42% H: 0.0% C: 0.0%
fda cancer blood therapy

Incyte Gets Phase II Win, Targets Blockbuster Dupixent in Skin Disease
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -1.28% | O: 0.57% H: 0.0% C: 0.0%
disease dupixent skin

Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 0.95% | O: 1.17% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 400K

Health Technology

| -4.16% | O: -0.73% H: 1.52% C: 0.5%
positive blood care topline results study

Global Insulin Delivery Pen Market Research Report 2024-2032 with Competitive Analysis of Berlin-Chemie, Biocon, Eli Lilly, Novo Nordisk, Owen Mumford, Sanofi, and Ypsomed
Published: 2024-02-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -2.09% | O: -0.93% H: 0.0% C: 0.0%
report research global insulin market

Tube Packaging Market Forecast Report to 2028, Featuring Berry Global, Amcor, CCL Industries, EPL, Hoffmann Neopac, Huhtamaki, Montebello, VisiPak, Unette & Romaco Group
Published: 2024-02-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -2.09% | O: -0.93% H: 0.0% C: 0.0%
tube report group market

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170

Health Technology

| 0.68% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -5.29% | O: 1.8% H: 0.0% C: -1.82%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -8.08% | O: 0.29% H: 0.15% C: -0.13%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -6.88% | O: 0.8% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M

Health Technology

| 5.2% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.86 -0.27% 0.98% 14M

Health Technology

| -1.51% | O: 0.71% H: 0.48% C: -0.52%
ABBV | News | $167.8 -1.03% -0.02% 2.9M

Health Technology

| 2.37% | O: 0.85% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -4.92% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

JPM 2024: On the Ground in San Francisco
Published: 2024-01-12 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -10.69% | O: 0.71% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -8.07% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -9.35% | O: 0.06% H: 0.0% C: 0.0%

JPM 2024: On the Ground in San Francisco
Published: 2024-01-10 (Crawled : 16:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -8.33% | O: 0.06% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -8.6% | O: 0.13% H: 0.0% C: 0.0%

FDA Decisions: Astellas Hit with CRL for Claudin 18.2-Targeted Hopeful
Published: 2024-01-09 (Crawled : 16:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -8.52% | O: -0.18% H: 1.53% C: -0.62%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -8.12% | O: 0.23% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M

Health Technology

| -3.8% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -7.93% | O: 0.74% H: 0.0% C: 0.0%
fda

Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
Published: 2024-01-09 (Crawled : 16:00) - biospace.com/
SKYE | $12.85 -8.41% -9.23% 110K

Transportation and Warehousing

| 430.99% | O: -7.02% H: 29.11% C: 15.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -7.93% | O: 0.74% H: 0.0% C: 0.0%
obesity disease kidney bioscience clearance trial

Enoxaparin Sodium Market Size to Grow USD 5354.7 Million by 2029 at a CAGR of 8.3% | Valuates Reports
Published: 2024-01-08 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -7.39% | O: 2.07% H: 0.48% C: 0.48%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -6.86% | O: 1.16% H: 0.0% C: 0.0%
million market

Adimab Provides Year-End Update on 2023 Partnership Activities
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -7.39% | O: 2.07% H: 0.48% C: 0.48%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -7.7% | O: 0.47% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -6.86% | O: 1.16% H: 0.0% C: 0.0%
partnership update

FDA Decisions: Amgen, Zealand Hit with CRLs in NSCLC, Congenital Hyperinsulin...
Published: 2024-01-03 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -6.0% | O: 0.49% H: 0.0% C: -0.26%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -5.85% | O: 1.9% H: 0.0% C: -1.39%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -7.4% | O: 0.42% H: 0.5% C: 0.21%
ABT | News | $106.89 -0.65% -0.09% 4.2M

Health Technology

| -2.69% | O: 0.26% H: 0.1% C: -0.56%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -3.92% | O: 1.38% H: 0.0% C: 0.0%
fda

Adimab Announces Successful Resolution of Lawsuit Brought Against LinkedUp Bioscience and Tianti Biotherapeutics
Published: 2023-12-21 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -1.99% | O: -0.1% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -2.72% | O: -0.08% H: 0.0% C: 0.0%
bioscience

Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown
Published: 2023-12-20 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -2.05% | O: -0.39% H: 1.49% C: 0.32%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -2.52% | O: 0.21% H: 0.0% C: 0.0%
sanofi

← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →

symbols : SNY crawled time : 16:00

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : SNY crawled time : 16:00 save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : SNY crawled time : 16:00

save search